 | • レポートコード：MRC-IM30090 • 出版社/出版日：IMARC / 2022年10月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年140億ドルであった世界の抗真菌薬市場規模が2027年には174億ドルに達し、予測期間中、年平均3.7％成長すると予測しています。本調査レポートでは、抗真菌薬の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、医薬品クラス別（アゾール、エキノカンジン、ポリエン、アリルアミン、その他）分析、疾患別（皮膚糸状菌症、カンジダ症、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A.,Scynexis Inc.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の抗真菌薬市場規模：医薬品クラス別 - アゾールの市場規模 - エキノカンジンの市場規模 - ポリエンの市場規模 - アリルアミンの市場規模 - その他抗真菌薬の市場規模 ・世界の抗真菌薬市場規模：疾患別 - 皮膚糸状菌症における市場規模 - カンジダ症における市場規模 - その他疾患における市場規模 ・世界の抗真菌薬市場規模：地域別 - 北米の抗真菌薬市場規模 - アジアの抗真菌薬市場規模 - 欧州の抗真菌薬市場規模 - 中南米の抗真菌薬市場規模 - 中東・アフリカの抗真菌薬市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global antifungal drugs market size reached US$ 14.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 17.4 Billion by 2027, exhibiting a growth rate (CAGR) of 3.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. Some of the commonly used antifungal drugs include polyenes, azoles and allylamines. They specifically neutralize fungal agents and dermatophytes, such as candida and tapeworms, and aid in the treatment of athlete’s foot, ringworm, aspergillosis, candidiasis and fungal meningitis. These drugs are commonly available in over the counter (OTC) capsule, gel, liquid and pill variants or intravenous solutions that are injected directly into the bloodstream to minimize and prevent fungal infection.
Antifungal Drugs Market Trends:
The increasing prevalence of fungal and nosocomial infections is one of the key factors creating a positive outlook for the market growth. Antifungal drugs are effective against both systemic and superficial infections that are acquired from exposure to contaminated surfaces in hospitals or humid conditions. Moreover, the convenient availability of OTC drugs in both urban and rural areas is providing a thrust to the market growth. With the rising health consciousness among the masses, consumers are increasingly opting for OTC therapeutics to timely treat minor infections. Additionally, various product innovations, such as the development of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections, are acting as other growth-inducing factors. Pharmaceutical manufacturers are also investing extensively in the research and development (R&D) of novel therapeutics in the form of sprays, creams, tablets and injections with enhanced efficacy. Other factors, including significant growth in the pharmaceutical industry, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global antifungal drugs market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class and indication.
Breakup by Drug Class:
Azoles
Voriconazole (Vfend)
Posaconazole (Noxafil)
Clotrimazole (Canesten)
Isavuconazole (CRESEMBA)
Others
Echinocandins
Caspofungin (Cancidas)
Micafungin (Mycamine/ Funguard)
Others
Polyenes
Amphotericin (AmBisome)
Others
Allylamines
Terbinafine (Lamisil)
Others
Others
Breakup by Indication:
Dermatophytosis
Aspergillosis
Candidiasis
Invasive Candidiasis
Vulvovaginal Candidiasis (VVC)
Mouth/Throat/Esophageal Candidiasis
Others
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.
Key Questions Answered in This Report:
How has the global antifungal drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global antifungal drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the indication?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global antifungal drugs market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Antifungal Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Azoles
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Voriconazole (Vfend)
6.1.2.2 Posaconazole (Noxafil)
6.1.2.3 Clotrimazole (Canesten)
6.1.2.4 Isavuconazole (CRESEMBA)
6.1.2.5 Others
6.1.3 Market Forecast
6.2 Echinocandins
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Caspofungin (Cancidas)
6.2.2.2 Micafungin (Mycamine/ Funguard)
6.2.2.3 Others
6.2.3 Market Forecast
6.3 Polyenes
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Amphotericin (AmBisome)
6.3.2.2 Others
6.3.3 Market Forecast
6.4 Allylamines
6.4.1 Market Trends
6.4.2 Key Segments
6.4.2.1 Terbinafine (Lamisil)
6.4.2.2 Others
6.4.3 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Indication
7.1 Dermatophytosis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Aspergillosis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Candidiasis
7.3.1 Market Trends
7.3.2 Key Segments
7.3.2.1 Invasive Candidiasis
7.3.2.2 Vulvovaginal Candidiasis (VVC)
7.3.2.3 Mouth/Throat/Esophageal Candidiasis
7.3.2.4 Others
7.3.3 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Arcadia Consumer Healthcare Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Astellas Pharma Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Bayer AG
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 GlaxoSmithKline Plc
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 Merck & Co. Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Merck KGaA
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Novartis AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Pfizer Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Sanofi S.A.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Scynexis Inc.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
Figure 2: Global: Antifungal Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Antifungal Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Antifungal Drugs Market: Breakup by Drug Class (in %), 2021
Figure 5: Global: Antifungal Drugs Market: Breakup by Indication (in %), 2021
Figure 6: Global: Antifungal Drugs Market: Breakup by Region (in %), 2021
Figure 7: Global: Antifungal Drugs (Azoles) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Antifungal Drugs (Azoles) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Antifungal Drugs (Echinocandins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Antifungal Drugs (Echinocandins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Antifungal Drugs (Polyenes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Antifungal Drugs (Polyenes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Antifungal Drugs (Allylamines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Antifungal Drugs (Allylamines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Antifungal Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Antifungal Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Antifungal Drugs (Dermatophytosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Antifungal Drugs (Dermatophytosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Antifungal Drugs (Aspergillosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Antifungal Drugs (Aspergillosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Antifungal Drugs (Candidiasis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Antifungal Drugs (Candidiasis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Antifungal Drugs (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Antifungal Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: North America: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: North America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: United States: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: United States: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Canada: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Canada: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Asia-Pacific: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Asia-Pacific: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: China: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: China: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Japan: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Japan: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: India: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: India: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: South Korea: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: South Korea: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Australia: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Australia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Indonesia: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Indonesia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Europe: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Europe: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Germany: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Germany: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: France: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: France: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: United Kingdom: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: United Kingdom: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Italy: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Italy: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Spain: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Spain: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Russia: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Russia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Latin America: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Latin America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Brazil: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Brazil: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Mexico: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Mexico: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Middle East and Africa: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Middle East and Africa: Antifungal Drugs Market: Breakup by Country (in %), 2021
Figure 73: Middle East and Africa: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Global: Antifungal Drugs Industry: SWOT Analysis
Figure 75: Global: Antifungal Drugs Industry: Value Chain Analysis
Figure 76: Global: Antifungal Drugs Industry: Porter's Five Forces Analysis
• 日本語訳：抗真菌薬の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30090 ▷ お問い合わせ（見積依頼・ご注文・質問）